MK-677 for Appetite Control
Research, mechanism, dosing, and effectiveness of MK-677 for appetite control.
Quick Answer
MK-677 significantly increases appetite through ghrelin mimetic action.
Evidence Level
Human Trials
Typical Dose
10-25 mg daily
Results Timeline
Appetite increase within first dose
FDA Status
Research Only
How MK-677 Works for Appetite Control
Direct ghrelin receptor activation stimulates hunger.
About Appetite Control
Suppression of hunger signals and improved satiety for weight management.
Research Evidence
Studies show increases in GH and IGF-1 levels, improved sleep quality, and increased lean body mass. However, a clinical trial was stopped early due to heart failure concerns in elderly patients. FDA lists MK-677 as having significant safety risks. Never received FDA approval.
Dosing for Appetite Control
Recommended Dose
10-25 mg daily
Frequency
Once daily, often before bed
Administration
Oral
Duration
8-12 weeks or longer
Note: Oral GH secretagogue. Can cause water retention, increased appetite, and blood sugar issues. Some cycle it, others run year-round.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Increased appetite and hunger
- •Weight gain
- •Water retention
- •Insulin resistance
- •Elevated blood glucose
- •Anxiety
Frequently Asked Questions
Does MK-677 help with appetite control?
MK-677 significantly increases appetite through ghrelin mimetic action.
How does MK-677 work for appetite control?
Direct ghrelin receptor activation stimulates hunger....
What dose of MK-677 should I use for appetite control?
10-25 mg daily
How long until I see results?
Appetite increase within first dose
Other Peptides for Appetite Control
These peptides are also researched for appetite control.
Ipamorelin
Clinical TrialsA selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin. Considered one of the safest GHRPs.
CJC-1295
Clinical TrialsA synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates GH release from the pituitary. Often combined with a GHRP like Ipamorelin for synergistic effects.
Tesamorelin
FDAAn FDA-approved GHRH analog used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. One of the few peptides with FDA approval.
GHRP-6
Clinical TrialsOne of the first synthetic GH secretagogues developed. Strongly stimulates GH release and significantly increases appetite through ghrelin receptor activation.
Educational Information Only
This information about MK-677 for appetite control is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.